Imaging services firm Diagnostic Health Services of Dallas has engaged Prudential Securities to help the company explore “various alternatives to maximize DHS shareholder value.” The company did not specify what those alternatives might be, but
Imaging services firm Diagnostic Health Services of Dallas has engaged Prudential Securities to help the company explore various alternatives to maximize DHS shareholder value. The company did not specify what those alternatives might be, but they could include either acquisitions or a merger with another firm.
Any acquisitions could be complicated by the recent decline in Diagnostic Healths share price, however. The plunge of the stock market has cut the value of the companys stock in half, with DHS shares falling from around $10 a share in July to about $4.50 in mid-September. Shares of the firm were trading as high as $13 a share in late March. The lower value of DHS shares would make it more difficult to use stock as an acquisition vehicle.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.